Bringing the fundamentals into focus…
Back to Corcept Therapeutics Incorporated
How Corcept Therapeutics Incorporated stacks up
CORT · against 1,335 other Healthcare companies
Profitability
48/ 100
Below the middle of the pack.
Ranked #689 of 1,336 · scores higher than 48% of peers
Bars: peers in each 10-point band of the profitability score133 peers with a profitability score of 40–49, including CORT · Click a bar to see the companies
Why profitability scores 48?
Weighted metrics compared with all Healthcare companies.A mix: stronger return on assets, but weaker operating margin and return on invested capital than most Healthcare peers.
- a thinner operating margin: weaker than 66% of peers. Operating margin: 0.8% vs peer median 7.1%
- a lower return on invested capital: weaker than 62% of peers. Return on invested capital: 0.9% vs peer median 4.7%
- a higher return on assets: stronger than 78% of peers. Return on assets: 6.2% vs peer median 1.7%
Metric by metric
Position: dot = CORT, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | CORT | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Return on invested capitalHigher is better · 1,226 reported | 0.9% | 4.7% | 38% | 33% | |
| Operating marginHigher is better · 1,251 reported | 0.8% | 7.1% | 34% | 33% | |
| Return on assetsHigher is better · 1,315 reported | 6.2% | 1.7% | 78% | 33% | |
| Return on equityHigher is better · 1,252 reported | 8.2% | 3.2% | 65% | Context only | |
| Gross marginHigher is better · 1,394 reported | 98.3% | 45.9% | 97% | Context only |
Ranking by profitability score
Top 5 and the companies ranked around CORTScores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score